These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36037807)

  • 1. Polyphenol-Functionalized Cubosomes as Thrombolytic Drug Carriers.
    Yu H; Palazzolo JS; Ju Y; Niego B; Pan S; Hagemeyer CE; Caruso F
    Adv Healthc Mater; 2022 Nov; 11(21):e2201151. PubMed ID: 36037807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers.
    Yu H; Palazzolo JS; Zhou J; Hu Y; Niego B; Pan S; Ju Y; Wang TY; Lin Z; Hagemeyer CE; Caruso F
    ACS Appl Mater Interfaces; 2022 Jan; 14(3):3740-3751. PubMed ID: 35019268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteria-propelled microtubular motors for efficient penetration and targeting delivery of thrombolytic agents.
    Xie S; Mo C; Cao W; Xie S; Li S; Zhang Z; Li X
    Acta Biomater; 2022 Apr; 142():49-59. PubMed ID: 35158079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ultrasound contrast imaging properties of lipid microbubbles loaded with urokinase in dog livers and their thrombolytic effects when combined with low-frequency ultrasound in vitro.
    Ren ST; Kang XN; Liao YR; Wang W; Ai H; Chen LN; Luo HT; Fu RG; Tan LF; Shen XL; Wang B
    J Thromb Thrombolysis; 2014 Apr; 37(3):303-9. PubMed ID: 23943336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
    Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
    J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke.
    Kadir RRA; Bayraktutan U
    Cell Mol Neurobiol; 2020 Apr; 40(3):347-355. PubMed ID: 31552559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remaining perspectives of mutant and chimeric plasminogen activators.
    Lijnen HR; Collen D
    Ann N Y Acad Sci; 1992 Dec; 667():357-64. PubMed ID: 1309056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of Lys- and mini-plasminogen on clot lysis induced by recombinant urokinase and recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Davidson DJ; Lubbers NL; Reininger IM; Henkin J
    Thromb Res; 1996 Sep; 83(6):421-31. PubMed ID: 8885137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model.
    Collen D; Dewerchin M; Rapold HJ; Lijnen HR; Stassen JM
    Circulation; 1990 Nov; 82(5):1744-53. PubMed ID: 2121385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
    Absar S; Nahar K; Kwon YM; Ahsan F
    Pharm Res; 2013 Jun; 30(6):1663-76. PubMed ID: 23468049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
    Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
    J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis based on magnetically-controlled surface-functionalized Fe
    Chang M; Lin YH; Gabayno JL; Li Q; Liu X
    Bioengineered; 2017 Jan; 8(1):29-35. PubMed ID: 27689864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human hair derived uPA loaded capsules with dual near-infrared (I and II biowindows) laser responsive capabilities for multi-effective thrombolysis therapy.
    Fang C; Zhong Z; Zhang T; Jia S; Ding X; Zhou W; Wang X
    J Mater Chem B; 2020 Dec; 8(47):10854-10866. PubMed ID: 33185225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism of thrombolytic agents in vivo.
    Collen D; Stassen JM; Stump DC; Verstraete M
    Circulation; 1986 Oct; 74(4):838-42. PubMed ID: 3093116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The search for the ideal thrombolytic agent.
    Verstraete M
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.